Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ixabepilone and SBRT For Metastatic Breast Cancer

This study has been terminated.
(low accrual)
Information provided by (Responsible Party):
University of Texas Southwestern Medical Center Identifier:
First received: March 6, 2013
Last updated: October 23, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2023
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)